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Abstract
Background: The use of malaria rapid diagnostic tests (RDTs) has been widely advocated to improve Plasmodium
falciparum diagnosis, especially in settings where quality microscopy is not available. RDTs based on the detection
of histidine-rich protein 2 (HRP-2) can remain positive for several weeks after an infection is cured, due to the
persistence of HRP-2 antigens. As a result, test specificity may vary between age groups with different prevalence
of P. falciparum infection.
Methods: A community-based cross-sectional survey, carried out in southern Tanzania in July and August 2004,
evaluated the performance of the Paracheck Pf in comparison with microscopy (number of P. falciparum parasites/
200 leucocytes). A sample of 598 individuals living in an area of intense malaria transmission had demographic
data collected before an RDT was performed. HRP-2 test sensitivity, specificity, positive and negative predictive
values were calculated and compared between distinct age groups, using microscopy as “gold standard”.
Results: The overall malaria prevalence was 34.3% according to microscopy and 57.2% according to the HRP-2
test. The HRP-2 test had a sensitivity of 96.1%, a specificity of 63.1%, a positive predictive value of 57.6% and a
negative predictive value of 96.9%. The test sensitivity was higher (ranging from 98% to 100%) amongst people
less than 25 years of age, but decreased to 81.3% in older adults. The HRP-2 test specificity varied between age
groups, ranging from 25% among children of five to nine years of age, to 73% among adults aged 25 or more.
The test positive predictive value increased with malaria prevalence, while the negative predictive value was
consistently high across age groups.
Conclusions: These results suggest that the performance of HRP-2 tests in areas of intense malaria transmission
varies by age and the prevalence of P. falciparum infection. The particularly low specificity among children will lead
to the over-estimation of malaria infection prevalence in this group.
Background
Rapid diagnostic tests (RDTs) for malaria were developed
in the early 1990’s, and welcomed with great enthusiasm
as a tool to improve malaria diagnosis, especially in
remote areas of Africa where access to microscopy is
often limited due to the lack of resources and skilled
technicians. In such settings, malaria diagnosis frequently
relies on clinical criteria, which have a low specificity,
leading to overuse of malaria drugs and potentially exert-
ing increased drug pressure on malaria parasite popula-
tions leading to the selection of drug-resistant parasites.
The urgent need to deploy affordable and accurate RDTs
grew with the emergence of widespread resistance of
P. falciparum to chloroquine and sulphadoxine pyri-
methamine (SP). As a result, malaria treatment increas-
ingly relies on artemisinin combination therapy (ACT), a
drug regimen that is only cost-effective if it is targeted
exclusively at patients with a confirmed malaria diagnosis
[1]. One RDT type is based on the detection of histidine-
rich protein 2 (HRP-2), a water-soluble protein produced
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parum. HRP-2 persists after cure of active infections,
potentially leading to false-positive test results after
treatment.
According to the World Health Organization’s (WHO)
recommendations, RDTs should demonstrate a mini-
mum sensitivity of 95% (100% when parasite density is
above 100/μL), and a minimum specificity of 90% [2].
HRP-2 based assays have been tested in a wide range of
clinical settings and endemicity sites, though only
recently in a standardized and co-ordinated way [3]. In
areas of low endemicity, where the vast majority of
infections are symptomatic and affect all age groups
equally, HRP-2 based tests have been shown to have
satisfactory specificity, according to WHO standards
[4-6]. Conversely, when transmission is intense and per-
ennial, and the prevalence of parasitaemia in the popula-
tion is high, the tests have shown less consistent
performance results and might yield a large number of
false positive results. Table 1 presents HRP-2 test per-
formance estimates compared to microscopy in P. falci-
parum highly endemic areas as reported in previous
studies [7-12]. With the exception of one study, the test
specificity is consistently inferior to the minimum
required of 90%. Many studies have demonstrated that
the sensitivity of HRP-2 based tests declines sharply
when the parasite density falls below 100 to 500 para-
sites/μL [6,8,9,13-15].
A relatively small amount of research has been car-
ried out to investigate how the specificity of HRP-2
based tests, with microscopy as the “gold standard”,
varies between areas of distinct endemicity and malaria
prevalence. Their findings are summarized in Table 2,
and show a consistent decrease of the test specificity
with increasing prevalence of P. falciparum infection.
This is despite the short-comings of microscopy, the
performance of which varies according to the way in
which the slide is read [16]. Hopkins et al [17] sug-
gested that a proportion of HRP-2 false positive results
m a yh a v eb e e nt h er e s u l to fsub-patent parasitaemia
undetectable by microscopy and reported a change of
overall specificity in the whole study population from
71% to 88% when the microscopy results were cor-
rected by polymerase chain reaction (PCR) analysis.
The persistence of HRP-2 protein in the blood several
weeks after parasite clearance is known to limit the
potential usefulness of the test in highly endemic
areas, as positive results might be the result of recent
treated infections [11,14].
The study presented here was carried out in an area of
intense and perennial malaria transmission in Tanzania.
In such transmission settings, the prevalence of malaria
infection varies with age, and so the performance, espe-
cially the specificity, of HRP-2 based tests, might vary
between distinct age groups. This community-based
study aims to estimate and compare the sensitivity,
specificity, positive predictive value (PPV) and negative
predictive values (NPV) of an HRP-2 based assay
between age groups, using microscopic examination of
blood smears as the “gold standard”.
Methods
Study area
This study was nested within a household baseline survey
carried out in 2004 in the Tandahimba district of Mtwara
region southern Tanzania. The study area and survey are
described in more detail elsewhere [18]. Malaria cases
present to health facilities all year round and parasitae-
m i ap r e v a l e n c ei nt h ec o m m u n i t yr i s e ss h a r p l yo v e rt h e
first few months of life, consistent with intense malaria
transmission. Plasmodium falciparum is the main species
responsible for malaria in Tanzania, with Plasmodium
malariae and Plasmodium ovale occurring in less than
5% of infections, and usually mixed with P. falciparum.
Plasmodium vivax is only occasionally found. The coun-
try’s national strategy against malaria at the time of the
survey relied on early treatment of episodes with sulpha-
doxine/pyrimethamine (SP) as the first-line drug and
Table 1 Studies of HRP-2 performance compared to microscopy, in P. falciparum endemic areas
Reference Location Study population Transmission (prevalence of positive blood
smear in the study population)
Sensitivity Specificity
Beadle [8] Kenya Children aged 9 to 14 years Hyperendemic (86%) 87% 88%
Swathout[11] Democratic
Republic of Congo
Symptomatic children aged 6-59
months
Highly endemic and seasonal 100% 52%
Huong [9] Vietnam Symptomatic and control
individuals aged 4-60 years
Hyperendemic 96% 100%
Guthmann [7] Uganda Symptomatic individuals Hyperendemic (57%) 97% 88%
Williams [12] Tanzania Symptomatic individuals of all age Hyperendemic (32%) 94% 89%
Shiff [10] Tanzania na Holoendemic 89% 88%
na = not applicable.
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insecticide-treated bed nets to reduce exposure.
Sampling method
Eight clusters of 30 households were sampled from sub
villages of Litehu and Namikupa divisions of Tandahimba
district using a modified EPI-type sampling scheme, such
that each household in a division had an equal chance of
being included in the sample [18]. A sequential series of
649 individuals of all ages constituted our study sample
and had a microscopic examination of a blood smear per-
formed in a research laboratory with quality assurance
procedures.
Data collection
This cross-sectional survey was carried out during July
and August 2004 by two groups of seven experienced
field workers accompanied by a supervisor. Villages
were visited one day before the survey, and an invitation
letter left in each of the selected households. A modular
questionnaire was used to collect data on age, sex, loca-
tion of household, demographic characteristics and
various health-related information. All household mem-
bers were invited for a malaria check by RDT and a
small quantity of blood was collected on a filter paper.
The teams collected, stained and stored blood slides for
subsequent microscopic examination.
Laboratory techniques
The HRP-2 test used to detect P. falciparum parasitae-
mia was the Paracheck rapid diagnostic test device
(Orchid Biomedical Systems, Goa, India). A Swahili ver-
sion of the technical sheet was developed to provide the
details of the testing procedure for the field workers.
A training session was conducted by an experienced
laboratory technician beforeap r a c t i c es e s s i o ni nt h e
classroom, followed by a supervised pilot of all proce-
dures in the field. Blood films were prepared by experi-
enced laboratory assistants and labelled with a unique
sample identification number before transportation to
the research laboratory where they were stained with
Giemsa and the number of asexual and sexual P. falci-
parum parasites per 200 leucocytes was counted. All
blood slides were read twice by two independent techni-
cians, and the results compared. A third reading was
performed in case of positive-negative or species dis-
agreement, or if the ratio of two positive results was
greater than 1.5 or less than 0.67 with an absolute dif-
ference in parasite density of less than 30 parasites/μl.
The definitive parasite count was then calculated assum-
ing a white blood cell count of 8,000/μL.
Data processing and analysis
Data were entered into hand held computers at the
point of data collection [19]. Standard range and consis-
tency checks were performed at the time of data entry.
Data collected via the questionnaire and relevant to the
study question were extracted and linked to the labora-
tory results through the individual identification num-
bers. Complete microscopy, RDT and demographic data
were available for 598 individuals. The microscopic
examination of blood slides revealed the presence of
gametocytes in nine of these blood samples, all of which
also had asexual forms.
After each linkage, a consistency check was performed
for the variables common to the various data sets. Data
were analyzed using Stata (version 8, College Station,
Texas, USA), according to a pre-defined analytical plan.
The study sample was divided into four age groups on
the basis of prevalence of parasitaemia: 0 to 4 years, 5
to 9 years, 10 to 24 years, and 25 years and above.
Three categories of parasite densities density were cre-
ated among individuals with a positive blood smear,
with cut-off points at 500 and 5,000 parasites/μL.
Malaria prevalence was calculated in each category of
age, sex and geographical location, and reported with a
Table 2 Studies comparing HRP-2 performance between
areas of different P. falciparum endemicity, using
microscopy as a “gold standard”
Reference Setting Prevalence of
positive blood
smears in the study
population (level of
malaria
transmission as
reported by the
author)
Sensitivity Specificity
Mharakurwa
[24]
Zimbabwe 10% (hypoendemic) 91% 92%
40% (hyperendemic) 95% 85%
59% (mesoendemic) 93% 72%
Hopkins [17] Uganda 4% (hypoendemic) na 98%
33 to 85%
(hyperendemic)
na 55%
Mboera [14] Tanzania 4% (unstable, prone
to outbreaks)
92% 99%
14% (unstable, prone
to outbreaks)
97% 97%
22% (unstable, prone
to outbreaks)
84% 91%
49% (unstable, prone
to outbreaks)
98% 90%
46% (perennial) 81% 95%
Abeku [25] Tanzania 1% (hypoendemic) 90% 100%
49% (mesoendemic) 91% 65%
na = not applicable.
Note: The studies examined different volumes of blood before declaring a
slide negative: studies [26,12] examined 100 fields and study [9] 200 fields
before declaring a slide negative; study [22] declared slides negative if no
parasite was seen by the time 400 white blood cells counted.
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standard”, each HRP-2 result was categorized as true
positive (TP), true negative (TN), false positive (FP) or
false negative (FN), so that sensitivity (TP/TP+FN), spe-
cificity (TN/TN+FP), positive predictive value (TP/TP
+FP) and negative predictive value (TN/TN+FN) could
be calculated in each age group, with their 95% confi-
dence interval. The test performance was also evaluated
for categories of parasite density. In accordance with the
study design, all measurement of malaria prevalence and
HRP-2 test performance were performed using the “svy”
command in STATA, in order to account for the sam-
pling strategy. Geometric means of parasite densities of
positive blood slides between age groups were computed
on a logarithmic scale, back-transformed and compared
using a one-way analysis of variance (ANOVA).
Proportions were compared using Fisher’se x a c tt e s t ,
and tests for trend were performed using linear regres-
sion. A logistic regression model was used to assess the
variation of test sensitivity between age groups, adjusting
for parasite density. A P-value < 0.05 was considered
statistically significant.
Ethical aspects and informed consent
An information sheet about the study was drawn up in
Swahili, and read out to each household head before
written informed consent was sought. In the event of a
positive HRP-2 test result, study participants were
offered treatment, according to the national guidelines.
This study was approved by the ethics committees of
the Ifakara Health Institute (formerly Ifakara Health
Research and Development Centre), the Tanzanian
National Medical Research Co-ordinating Committee,
the London School of Hygiene and Tropical Medicine
and the Swiss Tropical& Public Health Institute (for-
merly Swiss Tropical Institute).
Results
Baseline characteristics of the sample and P. falciparum
infection prevalence
Sampled individuals were equally distributed across two
divisions (Litehu and Namikupa) of Tandahimba Dis-
trict. Each of those two divisions is divided into three
wards, where the sample population was approximately
equally distributed (Table 3). Among the 598 indivi-
duals, 45 were children under two years of age and 543
were aged two years or more. Microscopy identified
P. falciparum infections in 205 of the 598 blood smears.
The sample age distribution is presented in Figure 1,
along with malaria prevalence according to microscopy
by five-year age groups.
The HRP-test yielded positive results for 342 out of
the 598 blood specimens (57.2%, [95% CI 45.9-68.5%].
Plasmodium falciparum infection prevalence based on
microscopy and HRP-2 test, by baseline characteristics,
is presented in Table 3. According to microscopy, 34.3%
[95% CI 26.5-42.0%] of the study sample was infected
with P. falciparum and no significant differences were
found between genders or across divisions (Table 3).
The malaria prevalence varied between wards, ranging
from 20% in Mkonjowano to 42.3% in Mkoreha (p <
0.001). The prevalence increased in childhood, from
64% in children below the age of five, to 73% in children
aged five to nine years, before decreasing with increasing
age in older children and adults. The difference of
malaria prevalence between age categories was statisti-
cally significant (p < 0.001).
HRP-2 test performance
The HRP-2 test performance results by age group are
summarized in Additional file 1, and graphically illustrated
in Figure 2. Overall, the HRP-2 based test demonstrated a
sensitivity of 96.1% [95% CI 92.5-98.3%], a specificity of
63.1% [95% CI 58.1-67.9%], a positive predictive value
(PPV) of 57.6% [95% CI 52.2-62.9%] and a negative predic-
tive value (NPV) of 96.9% [95% CI 93.9-98.6%].
The HRP-2 test sensitivity was consistently high among
children and young adults, but decreased to 81% in
adults above 25 years of age. HRP-2 test specificity var-
ied dramatically with age, from 25% among individuals
of five to nine years of age, to 73% among individuals
aged 25 years or more. As the prevalence of malaria
infection differed between age groups, the test specificity
appeared to decrease with increasing malaria prevalence.
The PPV of the HRP-2 test decreased as age increased,
while its NPV, on the contrary, remained steady at a
high value across age groups.
No evidence of a difference in sensitivity across cate-
gories of parasite density was found (Table 4). Children
below five years of age had the highest parasitaemia,
and the density decreased significantly as age increased
(P < 0.001) (Table 5). However, parasite densities were
generally low. Adjustment for parasite density did not
alter the association between test performance and age
groups. Among the eight false negative HRP-2 test
results, six had a parasite density less than 500 para-
sites/μL, while the two others had a parasite density of
2,500 and 10,500 parasites/μL. The majority of false
negative results (six out of eight) were individuals
belonging to the older age group.
Discussion
This paper has evaluated HRP-2 test performance in
people of distinct age groups living in an area of intense
P. falciparum transmission. The age pattern of parasi-
taemia and the high prevalence of P. falciparum infec-
tion in the childhood population indicate the intense
malaria transmission in our study area.
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younger age groups, in keeping with the findings of pre-
vious studies in similar settings [7,9,11,12]. There was
no evidence that the lower sensitivity in people aged 25
years or more was due to lower parasite density in older
people. Numerous studies have shown that HRP-2 tests
might fail to detect low-level parasitaemia [6,8,9,13-15].
In the current study, two cases of P. falciparum infec-
tion with high parasite density were undetected by the
test. While similar reports exist [20-22], the cause has
not been elucidated. It has been suggested that the
HRP-2 test sensitivity could be affected by the variability
of the target antigen in specific settings [23] but this
hypothesis is unlikely to explain the findings in the cur-
rent study as antigenic polymorphism is geographically
based. An alternative hypoth e s i si st h a ta g ed e p e n d e n t
immune status might lower HRP-2 test sensitivity, inde-
pendently of parasite density [15].
With respect to the HRP-2 test specificity, over one third
of the individuals with a positive HRP-2 test result had a
negative blood slide. The overall HRP-2 test specificity in
our study is substantially lower than that found by all but
one previous study sharing a similar methodology in simi-
lar malaria transmission settings [7-12,14,17,24]. In addi-
tion, the current study found that the test specificity
varied with age, and was inversely related to the preva-
lence of positive blood slides in different age groups, i.e.
the specificity decreased as malaria prevalence increased.
These findings corroborate the results of a recent study
where the investigators found an overall specificity of 65%,
and a decrease in specificity with decreasing age and
increasing malaria prevalence in symptomatic patients
[25]. Another study reported similarly low HRP-2 test spe-
cificity (52%) in symptomatic children under five years of
age in an area of intense transmission [11].
These striking findings have to be interpreted with
some caution as this difference may have arisen for var-
ious methodological reasons. Although the microscopic
examination of blood slides was subject to quality con-
trol, its use as “gold standard” might have been proble-
matic, as it does not have perfect sensitivity. In areas of
intense malaria transmission, a high proportion of the
population carries low level of parasites at any given
time. It is well established that PCR has a sensitivity
superior to microscopy when the parasite density is low
[26]. Previous studies suggest that a proportion of false
positive HRP-2 results are due to sub-patent parasitaemia
undetectable by microscopy [17,27].
T h ev a s tm a j o r i t yo fc o m p a r a b l ep u b l i s h e ds t u d i e so n
HRP-2 performance using microscopy as a “gold stan-
dard” in areas of intense malaria transmission recruited
symptomatic participants at health facilities. The sam-
ples in this study were from mainly asymptomatic parti-
cipants. Therefore, it is possible that the proportion of
Table 3 Plasmodium falciparum infection prevalence by baseline characteristics, according to blood smear microscopic
examination and HRP-2 test
Microscopy Rapid diagnostic test
No of observations Prevalence (%) 95% CI P-value (†) Prevalence (%) 95% CI P-value (†)
Sex 0.18 0.54
Female 320 31.3 [23.3-40.5] 56.3 [46.2-65.8]
Male 278 37.8 [28.2-48.5] 58.1 [44.0-71.3]
Geographical location
Division 0.40 0.93
TAN Litehu 303 31.7 [20.4-45.7] 56.8 [37.0-74.6]
TAN Namikupa 295 37.0 [30.9-43.5] 57.6 [46.6-67.9]
Ward 0.029 < 0.001
Mkoreha 97 42.3 [32.3-52.3] 67.0 [57.5-76.5]
Lyenje 109 38.5 [29.2-47.8] 70.6 [62.0-79.3]
Mihambwe 106 35.8 [26.6-45.1] 54.7 [45.1-64.4]
Chaume 99 35.4 [25.8-44.9] 56.6 [46.6-66.5]
Kitama 92 32.6 [22.8-42.4] 51.1 [40.7-61.5]
Mkonjowano 95 20.0 [11.8-28.2] 41.1 [31.0-51.1]
Age <0.001 <0.001
0 to 4 years 104 63.5 [49.4-75.5] 76.9 [64.1-86.2]
5 to 9 years 73 72.6 [54.2-85.6] 91.8 [82.3-96.4]
10 to 24 years 138 39.1 [26.8-53.1] 73.2 [54.3-86.2]
>= 25 years 283 11.3 [7.8-16.1] 33.2 [24.0-44.0]
Total 598 34.3 [26.5-42.0] 57.2 [45.9-68.5]
(
†) Fisher’s exact test.
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i no t h e rs t u d i e s .T h i sh y p o t h e s i si sa l s os u p p o r t e db y
the relatively low mean parasite density in this study’s
sample.
It has been reported that the RDT can stay positive for
more than five weeks after successful treatment, because
of prolonged persistence of HRP-2 antigen in the circula-
tion after parasite death [11]. Information on recent past
anti-malarial treatment was not elicited for the majority
of the study population, and a high proportion of false
positives may have been the result of recent treated infec-
tions, and these are likely to have been more frequent in
younger age groups. This effect may be exaggerated if
enhanced immunity acquired with age hastens the clear-
ance of HRP-2 antigens. In this respect, rapid diagnostic
tests based on detection of the parasite’s lactate dehydro-
genase (pLDH) are less likely to suffer the variable speci-
ficities in different age groups that we document because
p-LDH is cleared from the circulation rapidly on effective
treatment of infection.
HRP-2 tests are attractive because they are rapid and
relatively easy to perform, and do not require equipment
or electricity. However, our results suggest that their
interpretation needs caution. As the risk of malaria
infection depends mostly on the intensity of malaria
transmission, the use of protective measures against
infection and age-dependent immunity against P. falci-
parum, it seems reasonable to deduce that the different
age groups in our study reflect distinct categories of like-
lihood of infection. As the HRP-2 assay’s positive predic-
tive value varies widely with the likelihood of current or
recent infection at the time the test is performed, its use
for the comparison of malaria prevalence between differ-
ent age groups in a given malaria transmission setting, or
for the comparison of malaria prevalence between popu-
lations living in different transmission settings, might be
misleading. In populations with a high likelihood of
infection, in whom test specificity is expected to be rela-
tively low, the use of an HRP-2 test to evaluate the
impact of a protective intervention will tend to under-
estimate the effect of the intervention. Such comparisons
may be more robust if based on blood slide or molecular
data.
When HRP-2 tests are used for primary diagnosis in
area of intense transmission, our results suggest a risk
of malaria over-diagnosis in children, which might have
serious consequences as the diagnosis of non-malaria
febrile illnesses might be missed or delayed. This
Figure 1 Sample age distribution and malaria prevalence by 5-year age groups. Number of individuals in each 5-year age group (blue
columns). Malaria prevalence according to microscopy in each 5-year age group (black line).
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cificity with age is less marked in symptomatic indivi-
duals, who will tend to have a higher parasitaemia, but
warrants further investigation. In practice, clinicians
should bear in mind that their therapeutic and case-
management decisions should not exclusively be based
on the HRP-2 test result but should take into considera-
tion the age of the patient, the clinical presentation
(suggesting a non-malaria pathology) and a detailed his-
tory of recent drug treatment.
Conclusions
The relevance of HRP-2 based assay results depends
on the malaria transmission profile, the age of the
patient and the aim of testing. HRP-2 test users should
be aware of its very low specificity in some population
age groups and malaria transmission settings, when
compared with microscopy. HRP-2 test performance
against PCR should be investigated in different trans-
mission settings to determine the proportion of false
positive results due to sub-patent parasitaemia. Com-
parison against PCR is likely to reduce variation in
specificity but strong theoretical grounds remain to
expect that the phenomenon of variation in test per-
formance in different age groups and transmission set-
tings will remain.
Figure 2 HRP-2 test performance by 5-year age group. HRP-2 test sensitivity (black circles), specificity (red squares), positive predictive value
(orange triangles) and negative predictive value (green diamonds) by 5-year age group. Malaria prevalence according to microscopy (blue bars).
Table 4 HRP-2 test sensitivity by category of parasite
density
No of parasites/μL No of observation Sensitivity 95% CI
<500 81 92.6% [78.0-97.8]
500-4999 74 100% -
>5000 50 96.0% [81.7-99.2]
P value (Fisher’s exact test) 0.13.
Table 5 Mean parasite density by age group among
individuals with a positive blood slide
Parasite density
Age category
(years)
No of
observation
Parasites/μL
(*)
95% CI
0-4 66 3222 [2196-
4726]
5-9 53 1349 [864-2106]
10-24 54 512 [372-706]
25-+ 32 335 [206-547]
Total 205 1118 [887-1408]
P value (Anova test) < 0.001.
(*) Geometric means of parasites density in positive slides.
Laurent et al. Malaria Journal 2010, 9:294
http://www.malariajournal.com/content/9/1/294
Page 7 of 9Additional material
Additional file 1: HRP-2 test performance by age groups and
categories of likelihood of malaria infection.( †) Fisher’s exact test. (±)
Test for a linear trend.
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